92 related articles for article (PubMed ID: 28640095)
1. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
[TBL] [Abstract][Full Text] [Related]
2. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
Morimoto K; Kim SJ; Tanei T; Shimazu K; Tanji Y; Taguchi T; Tamaki Y; Terada N; Noguchi S
Cancer Sci; 2009 Jun; 100(6):1062-8. PubMed ID: 19385968
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
Abourbih S; Sircar K; Tanguay S; Kassouf W; Aprikian A; Mansure J; Brimo F
World J Surg Oncol; 2013 Nov; 11():298. PubMed ID: 24266898
[TBL] [Abstract][Full Text] [Related]
4. Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma.
Yang CK; Wang XK; Liao XW; Han CY; Yu TD; Qin W; Zhu GZ; Su H; Yu L; Liu XG; Lu SC; Chen ZW; Liu Z; Huang KT; Liu ZT; Liang Y; Huang JL; Xiao KY; Peng MH; Winkle CA; O'Brien SJ; Peng T
PLoS One; 2017; 12(8):e0182208. PubMed ID: 28792511
[TBL] [Abstract][Full Text] [Related]
5. Luminal B Breast Cancer Coexpressing
Ozaki A; Matsuda A; Maemura Y; Tada Y; Kasai T; Nagashima Y; Onaga C; Hara Y; Kitabatake K; Tsukimoto M; Tamori S; Sasaki K; Ohno S; Akimoto K
Anticancer Res; 2024 Jan; 44(1):37-47. PubMed ID: 38160009
[TBL] [Abstract][Full Text] [Related]
6. Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value.
Alhudiri I; Nolan C; Ellis I; Elzagheid A; Green A; Chapman C
Breast Cancer Res Treat; 2024 Jul; 206(1):143-153. PubMed ID: 38578521
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen enhances stemness and promotes metastasis of ERα36
Wang Q; Jiang J; Ying G; Xie XQ; Zhang X; Xu W; Zhang X; Song E; Bu H; Ping YF; Yao XH; Wang B; Xu S; Yan ZX; Tai Y; Hu B; Qi X; Wang YX; He ZC; Wang Y; Wang JM; Cui YH; Chen F; Meng K; Wang Z; Bian XW
Cell Res; 2018 Mar; 28(3):336-358. PubMed ID: 29393296
[TBL] [Abstract][Full Text] [Related]
8. ALDH1A1 is a marker of astrocytic differentiation during brain development and correlates with better survival in glioblastoma patients.
Adam SA; Schnell O; Pöschl J; Eigenbrod S; Kretzschmar HA; Tonn JC; Schüller U
Brain Pathol; 2012 Nov; 22(6):788-97. PubMed ID: 22417385
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of stem cell markers in triple-negative breast cancer.
Almási S; Nagy Á; Krenács T; Lantos T; Zombori T; Cserni G
Pathol Oncol Res; 2023; 29():1611365. PubMed ID: 38188613
[TBL] [Abstract][Full Text] [Related]
10. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
[TBL] [Abstract][Full Text] [Related]
11. Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity?
Mousa NA; Hussein A; Elemam NM; Mohammed G; Elwany M; Basha T; AlHammadi AA; Majzob RS; Talaat IM
Cancer Med; 2024 Feb; 13(3):e7004. PubMed ID: 38400679
[TBL] [Abstract][Full Text] [Related]
12. High serum levels of leucine-rich α-2 glycoprotein 1 (LRG-1) are associated with poor survival in patients with early breast cancer.
Göbel A; Rachner TD; Hoffmann O; Klotz DM; Kasimir-Bauer S; Kimmig R; Hofbauer LC; Bittner AK
Arch Gynecol Obstet; 2024 Jun; 309(6):2789-2798. PubMed ID: 38413424
[TBL] [Abstract][Full Text] [Related]
13. The Prognostic Impact of Retinoid X Receptor and Thyroid Hormone Receptor alpha in Unifocal vs. Multifocal/Multicentric Breast Cancer.
Zehni AZ; Batz F; Vattai A; Kaltofen T; Schrader S; Jacob SN; Mumm JN; Heidegger HH; Ditsch N; Mahner S; Jeschke U; Vilsmaier T
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478016
[TBL] [Abstract][Full Text] [Related]
14. Increased Expression of PHGDH and Prognostic Significance in Colorectal Cancer.
Jia XQ; Zhang S; Zhu HJ; Wang W; Zhu JH; Wang XD; Qiang JF
Transl Oncol; 2016 Jun; 9(3):191-6. PubMed ID: 27267836
[TBL] [Abstract][Full Text] [Related]
15. Aldehyde dehydrogenase 1 family: A potential molecule target for diseases.
Duan X; Hu H; Wang L; Chen L
Cell Biol Int; 2024 May; ():. PubMed ID: 38800962
[TBL] [Abstract][Full Text] [Related]
16.
Zhou Y; Xue W; Meng X; Bhandari A; Zeng H; Kc R; Hirachan S; Xia E
Breast Cancer (Dove Med Press); 2024; 16():71-89. PubMed ID: 38476642
[TBL] [Abstract][Full Text] [Related]
17. ASPP1/2 positive patients with invasive breast cancers have good prognosis.
Wang C; Li K; An J; Lv X; Ma W; Wang Y; Meng N; Yun T; Zhao T
Heliyon; 2023 Oct; 9(10):e20613. PubMed ID: 37886763
[TBL] [Abstract][Full Text] [Related]
18. HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells.
Gallardo-Pérez JC; Adán-Ladrón de Guevara A; Marín-Hernández A; Moreno-Sánchez R; Rodríguez-Enríquez S
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1679-1690. PubMed ID: 28648642
[TBL] [Abstract][Full Text] [Related]
19. Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation.
Hara T; Iwadate M; Tachibana K; Waguri S; Takenoshita S; Hamada N
Strahlenther Onkol; 2017 Oct; 193(10):848-855. PubMed ID: 28642964
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of ALDH1A1 expression in early invasive breast cancer.
Althobiti M; El Ansari R; Aleskandarany M; Joseph C; Toss MS; Green AR; Rakha EA
Histopathology; 2020 Sep; 77(3):437-448. PubMed ID: 32369651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]